Livkon Pharmaceuticals Private Limited, a active private limited company, was established on 15 March 2014 in Ambernath, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100MH2014PTC254357. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Livkon Pharmaceutical Private Limited, Livkon Pharmaceuticals Private Limited. It upholds a compliant status. Its leadership includes Hema Shirish Ahirekar (Director), Shirish Dnyaneshwar Ahirekar (Director). Past directors included Rakesh Kasturilal Bakshi, Rajesh Mani Sarvjeet Mani Tripathi, Sushma Santosh Bhosale. It holds no open charges and ₹1.95 M settled loans. Its latest AGM occurred on 29 March 2025, with the balance sheet filed on 31 March 2024. It is based at Plot No. F-2/4, Kansai Midc, Near Amp Gate Ambernath West, Ambernath, Maharashtra, 421501.
U24100MH2014PTC254357
254357
15 March 2014
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Livkon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hema Shirish Ahirekar | Director | 28 Oct 2015 | Current |
| Shirish Dnyaneshwar Ahirekar | Director | 15 Mar 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 08 Dec 2014 | Past |
| Pramod Abcsdd | Director | 19 Dec 2019 | Past |
| Pramod Abcsdd | Additional Director | 28 Oct 2015 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 28 Oct 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
D.K. Livkon Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 202.07% increase. The company also saw a substantial fall in profitability, with a 138.87% decrease in profit. The company's net worth observed a substantial decline by a decrease of 115.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Livkon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,950,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jan 2018 | Others | ₹1.95 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Livkon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Livkon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Livkon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Livkon Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Mar 2025 as per latest MCA records. was completed.
The activity Livkon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity A charge registered on 11 Jan 2018 via Charge ID 100174760 with Others was fully satisfied on 20 Jun 2023. was completed.
The activity A charge with Others amounted to Rs. 1.95 M with Charge ID 100174760 was registered on 11 Jan 2018. was completed.
The activity Hema Shirish Ahirekar was appointed as a Director was appointed as a Director on 28 Oct 2015 & has been associated with this company since 10 years 1 month . was completed.
Shirish Dnyaneshwar Ahirekar was appointed as a Director was appointed as a Director on 15 Mar 2014 & has been associated with this company since 11 years 8 months . was recorded as a recent event.
The CIN of Livkon Pharmaceuticals Private Limited is U24100MH2014PTC254357.
Livkon Pharmaceuticals Private Limited is headquartered at Plot No. F-2/4, Kansai Midc, Near Amp Gate Ambernath West, Ambernath, Maharashtra, 421501.
Livkon Pharmaceuticals Private Limited was incorporated on 15 March 2014.
The current directors of Livkon Pharmaceuticals Private Limited are
The primary industry of Livkon Pharmaceuticals Private Limited is Manufacturing.
Livkon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Livkon Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Livkon Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX